Safer Opioid Supply Program Evaluation: A comparison of SOS client outcomes from 2022 and 2023

The goal of the evaluation was to examine and compare self-reported client outcomes from 2022 and 2023. In both years, clients identified reduced use of drugs from unregulated market, reductions in overdose and increased access to health services since starting safer supply. This report also examines which medications (both opioid and stimulant) that participants would like to be prescribed and their preferred mode of administration for SOS medications.